Dendritic Cell-Related Immune Marker CD1C for Predicting Prognosis and Immunotherapy Opportunities of Lung Adenocarcinoma Patients.
Saved in:
| Title: | Dendritic Cell-Related Immune Marker CD1C for Predicting Prognosis and Immunotherapy Opportunities of Lung Adenocarcinoma Patients. |
|---|---|
| Authors: | Zhao J; Department of Pulmonary and Critical Care Medicine, The Yancheng Clinical College of Xuzhou Medical University, The First People's Hospital of Yancheng, No. 166, Yulong West Road, Yancheng, 224000, Jiangsu, P.R. China., Chen H; Yancheng Maternal and Child Health Care Hospital, Yancheng, 224000, Jiangsu, P.R. China., Sun J; Department of Pulmonary and Critical Care Medicine, The Yancheng Clinical College of Xuzhou Medical University, The First People's Hospital of Yancheng, No. 166, Yulong West Road, Yancheng, 224000, Jiangsu, P.R. China. xiaobai.1982@vip.163.com. |
| Source: | Applied biochemistry and biotechnology [Appl Biochem Biotechnol] 2024 Dec; Vol. 196 (12), pp. 8724-8740. Date of Electronic Publication: 2024 Jun 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Humana Press Country of Publication: United States NLM ID: 8208561 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-0291 (Electronic) Linking ISSN: 02732289 NLM ISO Abbreviation: Appl Biochem Biotechnol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1559-0291 |
|---|---|
| DOI: | 10.1007/s12010-024-04973-9 |
